Almac secures Covid-19 recovery
The initiative is being led by Innovate UK, the UK’s innovation agency, and is a SBRI competition, which will fund organisations to develop and demonstrate new products or services to help businesses and/or the public sector in the UK recover from the coronavirus pandemic in a sustainable manner, demonstrating the impact and potential of a clean growth-led recovery and transition to net zero.
Professor Tom Moody, VP Technology Development and Commercialisation, Almac Sciences and Arran Chemical Company (Ireland), will lead a team of experts to complete the project entitled ‘Manufacturing Oxidative Products’ over the next three months. The funding received from the SBRI will enable the team to demonstrate both innovative flow chemistry and biocatalytic routes to oxidative products as a technology platform for exploitation by UK fine chemical and pharmaceutical industries.
Advertisement
Hide AdAdvertisement
Hide AdThe findings of the project will then be submitted to phase 2 of the Sustainable Innovation Fund and, if successful, could receive additional funding of up to £3 million over a 1-year period to continue the innovative research, development and testing.
Professor Moody said: “The team and I are excited to receive this phase I award from Innovate UK enabling us to conduct vital research into a sustainable method of manufacturing an adequate supply of oxidative products. The coronavirus pandemic has affected many businesses, and indeed individuals, across the world and we are proud to have been selected based on our expertise and capability, to play our part in the sustainable recovery process.”
Innovate UK Executive Chair Dr Ian Campbell continued: “In these difficult times we have seen the best of British business innovation. The pandemic is not just a health emergency but one that impacts society and the economy. Almac’s project, along with every initiative Innovate UK has supported through this fund, is an important step forward in driving sustainable economic development. Each one is also helping to realise the ambitions of hard-working people.”
The Covid-19 pandemic has resulted in an unexpected and unparalleled disruption to UK jobs, businesses, the economy at large and society in general. Recovering will take considerable time and ongoing investment, but the opportunity exists to recover in a sustainable way, resulting in increased prosperity with lower carbon emissions. This news comes just one month after Almac announced it has been awarded a grant of $500,000 by the Covid-19 Therapeutics Accelerator towards developing cost effective, scalable processes for the production of the active pharmaceutical ingredient (API) of the drug remdesivir.
A message from the Editor:
Advertisement
Hide AdAdvertisement
Hide AdThank you for reading this story on our website. While I have your attention, I also have an important request to make of you.
In order for us to continue to provide high quality and trusted local news on this free-to-read site, I am asking you to also please purchase a copy of our newspaper whenever you are able to do so.
Our journalists are highly trained and our content is independently regulated by IPSO to some of the most rigorous standards in the world. But being your eyes and ears comes at a price. So we need your support more than ever to buy our newspapers during this crisis.
With the coronavirus lockdown having a major impact on many of our local valued advertisers - and consequently the advertising that we receive - we are more reliant than ever on you helping us to provide you with news and information by buying a copy of our newspaper when you can safely.
Advertisement
Hide AdAdvertisement
Hide AdYou can also enjoy unlimited access to the best news from across Northern Ireland and the UK by subscribing to newsletter.co.uk
With a digital subscription, you can read more than five articles, see fewer ads, enjoy faster load times, and get access to exclusive newsletters and content. Visit https://www.newsletter.co.uk/subscriptions now to sign up.
Thank you